On 2024-03-28, Monopar Therapeutics Inc. (MNPR) announced earnings per share of $-0.12 for the fiscal quarter ending 2023-12-31, beating the average analyst estimate of $-0.17.
The next expected annoucement date for quarterly earnings is 2024-05-09, with an average estimated earnings per share of $-0.17 for the fiscal quarter ending 2024-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-03-28 | 2023-12-31 | $-0.17 | $-0.12 |
| 2023-11-09 | 2023-09-30 | $-0.19 | $-0.14 |
| 2023-08-10 | 2023-06-30 | $-0.19 | $-0.16 |
| 2023-05-11 | 2023-03-31 | $-0.20 | $-0.19 |
| 2023-03-23 | 2022-12-31 | $-0.21 | $-0.22 |
| 2022-11-10 | 2022-09-30 | $-0.23 | $-0.19 |
| 2022-08-11 | 2022-06-30 | $-0.21 | $-0.22 |
| 2022-05-12 | 2022-03-31 | $-0.24 | $-0.19 |
| 2022-03-24 | 2021-12-31 | $-0.18 | $-0.21 |
| 2021-11-12 | 2021-09-30 | $-0.22 | $-0.20 |
| 2021-08-12 | 2021-06-30 | $-0.21 | $-0.17 |
| 2021-05-13 | 2021-03-31 | $-0.22 | $-0.16 |
| 2021-03-25 | 2020-12-31 | $-0.15 | $-0.19 |
| 2020-11-12 | 2020-09-30 | $-0.15 | $-0.27 |
| 2020-08-06 | 2020-06-30 | $-0.25 | $-0.14 |
| 2020-05-07 | 2020-03-31 | -- | $-0.10 |
| 2020-03-27 | 2019-12-31 | $-0.07 | $-0.13 |